Behind-the-scenes photos show Zoo Miami gorillas prepped for big move to Chicago
Two of Zoo Miami's most iconic residents, silverback lowland gorillas Shango and Barney, have been medically cleared for transfer to Brookfield Zoo Chicago later this month, marking the end of an era for the South Florida zoo.
The 36-year-old, 448-pound Shango and his younger brother, 31-year-old, 415-pound Barney, underwent comprehensive medical examinations on Friday in preparation for their move.
The 36-year-old, 448-pound Shango and his younger brother, 31-year-old, 415-pound Barney, underwent comprehensive medical examinations on Friday in preparation for their move.
Zoo Miami
The procedures included blood work, X-rays, dental cleanings, tuberculosis tests, cardiac ultrasounds and vaccinations for rabies and tetanus. The exams, which were led by Zoo Miami veterinarians Dr. Marisa Bezjian and Dr. Nicholas Buscaglia and overseen by Chief of Animal Health Dr. Gwen Myers, confirmed that both gorillas are in good health, according to a release from Zoo Miami.
Specialized care was also provided by human cardiologist Dr. Ken Zide, along with sonographer Raquel McBean and cardiology fellow Dr. Kunal Lal.
Zoo officials said both gorillas have since made a full recovery and are back in their habitat until the relocation.
Zoo officials said both gorillas have since made a full recovery and are back in their habitat until the relocation.
Zoo Miami
Gorillas to join Brookfield Zoo's first bachelor troop
Once in Chicago, Shango and Barney will become the first bachelor troop displayed at Brookfield Zoo's James and Elizabeth Bramsen Tropical Forest. In the wild, bachelor troops consist of younger males who have left their family units or adults who haven't formed one, offering vital social interactions that benefit the health and survival of the species, Zoo Miami's Ron Magill said.
Western lowland gorillas are critically endangered, threatened by poaching, disease, and habitat destruction.
The brothers' transfer is part of the Association of Zoos and Aquariums Species Survival Plan, which supports gorilla conservation and education.
Shango and Barney's departure ends a 40-year Zoo Miami tradition
Barney and Shango were born at the San Francisco Zoo and arrived at Zoo Miami in 2017 from Sedgwick County Zoo in Kansas.
Their departure will allow Zoo Miami to begin renovations on its great ape habitat to meet updated Florida Fish and Wildlife Commission regulations, zoo officials said.
When they leave at the end of May, Zoo Miami will be without gorillas for the first time in over 40 years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
Advocates optimistic that Congress could renew downwinder compensation in budget bill
One year to the day since federal lawmakers let compensation for downwinders expire, advocates say they feel more optimistic than they have in months about getting an expansion of the program through Congress. Although a majority of senators voted to renew and expand the program last year, the bill was never considered in the House of Representatives. But some now see President Donald Trump's 'big, beautiful' budget bill as a potential vehicle and are urging lawmakers to include compensation in the Senate version of the bill. 'As we know, fallout knows no boundaries,' said Steve Erickson, a longtime volunteer with Downwinders Inc, during a press conference outside the Wallace F. Bennett Federal Building Tuesday. 'There's plenty of evidence — it's overwhelming, in fact — that hundreds of thousands of cancers were caused by atomic fallout, and so it's time that — past time now for some years — that RECA be expanded to cover far more of those who suffered from those unwitting exposures.' Erickson was referring to the Radiation Exposure Compensation Act of 1990, which provided some restitution to people with illnesses linked to exposure to nuclear fallout from tests conducted by the U.S. government at the Nevada Test Site and others. Downwinders from 10 counties in southern Utah were covered under the act, along with people who lived in northern Arizona and Nevada at the time of the tests. The act was renewed for two years in 2022, but advocates have sought to have the pool of eligible applicants be expanded to cover downwinders across several Western states – including all of Utah — and miners exposed to uranium in Missouri. Sen. Josh Hawley, R-Missouri, sponsored the Senate expansion bill last year and is said to be working on reintroducing some version of the legislation as part of the One Big Beautiful Bill Act. Utah downwinders say they've been in touch with Hawley's office and that the senator is optimistic about the progress being made behind the scenes. They praised Utah's congressional delegation for working toward a solution — Sen. Mike Lee and Rep. Celeste Maloy in particular, who sponsored a two-year extension of the program last year — but urged Utah's elected officials to support something similar to the expanded bill Hawley pushed last year. Lee gave a statement to advocates, saying, 'I am proud to work toward RECA reauthorization and to ensure that the Americans who rely upon it continue to receive the care they need.' The first nuclear test was conducted 80 years ago next month, and downwinders are urging Congress to act quickly to preserve compensation for aging Americans who are suffering from illnesses likely caused by exposure to radiation. They say the federal government has a responsibility to help those who were exposed to radiation from tests without knowledge of the long-term effects. 'I've watched families, friends, colleagues and neighbors suffer from the consequences of the decisions that were made. Those people had no say in any of those decisions,' Claudia Peterson, a downwinder from St. George, said in a statement. 'Tomorrow, I will be sitting at the bedside of my childhood friend as she goes through another surgery related to another cancer, and she is scared to death. There are no words to say what it takes to watch the heartache, to paint a true picture of watching a loved one suffer.' 'And the legacy is what has been left by decisions made by our government,' she added. A bipartisan group of 41 state lawmakers wrote to Congress urging the extension and expansion of the Radiation Exposure Compensation Act in April, but Erickson said he hasn't heard a response from Washington. Although the program has expired, the Justice Department has continued to process claims that were submitted prior to its sunset, but those are dwindling, and the program will soon be shuttered. 'Those few claims that are left are still being settled, and when they are done, the program is done, the doors will close, and it will shut down,' Erickson said. 'It'll be harder and more expensive to restart the Justice Department compensation program under RECA if it isn't renewed soon, so it's imperative that Congress act now.'
Yahoo
13 hours ago
- Yahoo
Feeling antsy in your legs at bedtime? This condition may be to blame
Sign up for CNN's Sleep, But Better newsletter series. Our seven-part guide has helpful hints to achieve better sleep. Karla Dzienkowski's daughter was 11 when she started coming into her mom's room at night saying she couldn't fall asleep because of a stabbing feeling in her legs. She had to walk to make it stop. The preteen became cranky and tired. Her grades started to slip, and she even fell asleep on a bench during a family trip to an amusement park, Dzienkowski said. It took three years, but Dzienkowski's family finally got an explanation for the girl's condition: restless legs syndrome. One study estimates 4% to 29% of adults in Western industrialized countries have restless legs syndrome. It is a condition that too few people can recognize in themselves, and many doctors don't know how to manage properly, said Dzienkowski, a nurse who is executive director of the Restless Legs Syndrome Foundation. Here is what experts want you to know about restless legs syndrome. 'Restless legs syndrome is a neurological disorder that is characterized by a need to move that is oftentimes associated with an uncomfortable feeling,' said Dr. John Winkelman, chief of the sleep disorders clinical research program at Massachusetts General Hospital and professor of psychiatry at Harvard Medical School. The uncomfortable feeling — described as crawling, aching, tingling or throbbing — is often in the legs and sometimes the arms, he added. Restlessness frequently happens when people with the condition are sitting or lying down, and it is relieved with movement, Winkelman said. Symptoms are more likely to occur when a person is at rest, most often at night, and because the syndrome interferes with sleep, it is classified as a sleep disorder, Winkelman said. In moderate to severe cases, people experience restless legs syndrome several times a week, and in the most extreme cases, symptoms can delay sleep for several hours, said Dr. Brian Koo, associate professor of neurology at Yale School of Medicine and director of the Yale Center for Restless Legs Syndrome. Two strong components play a role in who gets restless legs syndrome: genetics and iron levels. Restless legs syndrome often runs in families, and genetic markers make up about 20% of the prediction of who will get it, Winkelman said. Those with an iron deficiency are also more likely to get restless legs syndrome, including people who are pregnant, on dialysis, who are menstruating, who have anemia, or who are vegetarians, Winkelman said. Those on selective serotonin reuptake inhibitor antidepressants may also be vulnerable to restless legs syndrome, he added. The condition is twice as common in women as in men and much more common as people get older, Winkelman said. However, as Dzienkowski learned, children can have restless legs syndrome, too. To treat restless legs syndrome, a good first step is to look at what might be making the condition worse, Winkelman said. Alcohol, other medications and simple sugars may contribute to symptoms, Koo said. If iron is low — or even borderline low — oral iron supplements or intravenous iron infusions may help, Winkelman added. Dzienkowski also recommends having a 'bag of tricks' to manage symptoms, such as hot or cold packs, massages, walks or some mind-stimulating activity. 'For some reason … if you keep your mind engaged, it helps to keep symptoms at bay,' she said. There are medications that help if lifestyle changes and iron supplementation don't work. Many doctors will start with a class of drugs called alpha2-delta ligands, such as gabapentin or pregabalin, Koo said. For a long time, dopamine agonists were the first line of medications. But they are now prescribed infrequently because they can worsen restless legs syndrome over time, Winkelman added. The medications for the most severe cases are low-dose, long-acting opioid medications, Koo said. If you have discomfort that motivates you to move your legs at rest — particularly if doing so disturbs your sleep — talk to a doctor, Dzienkowski said. Not all medical professionals are well versed in restless legs syndrome, so asking for a referral to a sleep specialist may be helpful, she said. You should also get your lab work done, especially an iron panel with ferritin, a blood test that looks at how much iron your body has and how available it is for use, Dzienkowski said. 'The sooner you do it, the better, because you're just delaying diagnosis and treatment, which can be detrimental to your life,' she said. 'You don't realize that that sleepiness that you're feeling at work or the crankiness or you're not wanting to get out and do things could be the RLS bleeding into your daytime. … At least go have that conversation.'
Time Business News
2 days ago
- Time Business News
How Culture Shapes Our View of Wellbutrin for Anxiety
In today's globalized world, the way we understand and interpret mental health treatments is deeply influenced by cultural beliefs, values, and norms. One such medication that has garnered attention in recent years is wellbutrin anxiety. Originally approved as an antidepressant and smoking cessation aid, it has also been used off-label for treating anxiety in specific cases. However, public and medical perceptions of using Wellbutrin for anxiety vary widely depending on cultural background. Understanding how culture shapes our view of this drug provides insight not just into Wellbutrin's reception, but into broader societal attitudes about mental health and pharmacological treatment. When it comes to treating ADHD, stimulant medications play a crucial role in improving focus and reducing impulsivity. Two Vyvanse vs adderall prescribed options are Vyvanse and Adderall, each with distinct characteristics. Vyvanse is a prodrug, meaning it's inactive until metabolized in the body, leading to a smoother and longer-lasting effect. In contrast, Adderall contains a mix of amphetamine salts that act more quickly but can have a shorter duration. Both medications target similar brain chemicals but differ in onset time and side effects. Choosing between Vyvanse vs Adderall often depends on individual response and lifestyle needs. Culture plays a critical role in shaping how individuals perceive mental health, diagnose emotional distress, and seek treatment. In Western societies, particularly in the United States, there is a growing acceptance of using medication for managing mental health conditions like depression and anxiety. The biomedical model dominates—mental health is largely seen as a result of neurochemical imbalances, treatable through pharmaceutical intervention. This belief system naturally influences the openness toward medications like Wellbutrin, even for off-label uses such as anxiety. In contrast, in many non-Western cultures, mental health is more likely to be seen through spiritual, communal, or holistic lenses. Psychological distress might be attributed to personal failure, spiritual imbalance, or societal disharmony. These cultural frameworks often result in stigmatization of psychiatric drugs or skepticism about their necessity. As a result, someone in a collectivist culture might be more hesitant to use Wellbutrin for anxiety, fearing social judgment or believing that non-pharmacological methods like meditation, herbal remedies, or community support are more acceptable. One of the major cultural factors that influences the use of Wellbutrin is stigma—both internal and societal. In many cultures, there is significant stigma attached to taking psychiatric medication, often rooted in a belief that mental illness indicates personal weakness or failure. Even in countries like the U.S., where psychiatric drug use is widespread, people often express reluctance or shame in discussing their medication openly. Wellbutrin's branding as a 'non-typical' antidepressant and its use in smoking cessation has somewhat reduced this stigma for some users. It doesn't carry the same weight as more commonly used SSRIs like Prozac or Zoloft. However, when used for anxiety—a condition often seen as less severe or 'less legitimate' than depression in some circles—users may face added pressure or disbelief. Cultural norms that promote stoicism, self-reliance, or silence around emotional distress can further discourage individuals from accepting Wellbutrin as a viable treatment for anxiety. How a medication is marketed also plays a substantial role in shaping cultural perceptions. In the United States, direct-to-consumer pharmaceutical advertising is legal and widespread. Television ads often portray medications like Wellbutrin as life-changing tools, providing visual narratives of transformation—from despair to joy, from isolation to connection. This imagery feeds into a cultural narrative that medical solutions are the most efficient and desirable route to wellness. However, this is not the case globally. In countries where pharmaceutical advertising is restricted or banned, public knowledge of medications like Wellbutrin often comes from doctors or health professionals, not TV commercials or social media. As a result, cultural narratives about these drugs are more medically grounded and less emotionally driven. In such societies, Wellbutrin may be seen more clinically and less symbolically—as a neutral tool rather than a symbol of modern self-care or empowerment. Cultural differences in healthcare systems also affect the way Wellbutrin is prescribed and understood. In the United States, the healthcare model allows for a greater degree of patient choice and provider flexibility. Off-label use, such as prescribing Wellbutrin for anxiety, is relatively common. Physicians may be more willing to explore alternative applications of existing drugs, especially if patients advocate for them. In other countries, stricter regulations, standardized treatment protocols, and less patient involvement in treatment decisions can result in a more conservative approach. Doctors may hesitate to prescribe Wellbutrin for anxiety if it's not officially approved for that use, regardless of emerging evidence or individual cases. This cautious stance is not necessarily due to mistrust of the drug, but due to systemic differences in risk tolerance and adherence to evidence-based guidelines. How cultures define and handle emotions also deeply influences the acceptability of using medications like Wellbutrin for anxiety. In some Western cultures, expressing emotions openly and prioritizing emotional well-being is encouraged. Anxiety is increasingly seen as a legitimate health issue requiring treatment, and patients are encouraged to seek out solutions, whether therapeutic or pharmacological. In more reserved cultures, where emotional restraint and control are highly valued, anxiety might be normalized or downplayed. Instead of seeking treatment, individuals might be encouraged to 'tough it out' or turn to traditional healing practices. In these environments, suggesting a pharmaceutical solution like Wellbutrin may be met with resistance or disbelief—not necessarily because the drug is distrusted, but because the condition it treats isn't universally acknowledged in the same way. The rise of online health communities and social media platforms has begun to blur traditional cultural boundaries. People from different countries and backgrounds can now share their experiences with medications like Wellbutrin, creating a global dialogue. On platforms like Reddit, YouTube, and TikTok, individuals openly discuss the pros and cons of using Wellbutrin for anxiety. These discussions can demystify the drug for some, validate others' experiences, and challenge deeply ingrained cultural beliefs. Younger generations, especially digital natives, are more likely to seek health information online and adopt perspectives that differ from those of their parents or cultural predecessors. In some cases, this has led to increased openness about mental health and reduced stigma around medication use, even in cultures that historically resisted psychiatric intervention. As a result, cultural perceptions of Wellbutrin are gradually shifting, becoming more nuanced and inclusive. Wellbutrin's use for anxiety, while still considered off-label, offers a fascinating case study in how cultural beliefs shape medical treatment. From the stigma surrounding psychiatric medication to healthcare system practices and emotional expression norms, countless factors influence how this drug is perceived and utilized. While Western cultures may embrace Wellbutrin more readily as a modern solution to mental health struggles, non-Western societies often approach it with caution, shaped by different traditions, values, and healthcare infrastructures. As global conversations about mental health continue to evolve, it's essential to recognize that there is no single, universal view of medications like Wellbutrin. Each perspective is valid in its own cultural context. By understanding these cultural nuances, we can foster more inclusive, respectful, and informed approaches to mental health treatment across the world. TIME BUSINESS NEWS
